Consolidation Chemotherapy After Autologous Stem Cell Transplantation for Lymphoid Malignancies

• Status: Unknown status
• Trial end date: 2019-09-01
• Target enrollment: 0
• Participant gender: All

Summary

To imporve the outcome of patients with relapsed/refractory lymphoma, we conduct a clinical trial to test the efficacy and feasibility of consolidation chemotherapy after autologous stem cell transplantation

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Shanghai Jiao Tong University School of Medicine

Criteria

Inclusion Criteria:

• Patients with relapsed or refracotry NHL or HD: PR or SD after first line salvage chemotherapy;

• ECOG: 0-2

• Tbil < 1.5x ULN and AST/ALT <2.5x ULN

• With informed consent

Exclusion Criteria:

• Life expectancy < 3 months

• Women in pregnancy

• uncontrollable infection disease

• serum Cr >400mmol/l

• uncontroled diabetis and heart disease